It has been established that tumor cells can be distinguished from surrounding healthy tissue by electrical impedance. However, existing impedance measuring apparatus require direct contact or excision. In this work, we suggest the application of Biomimetic Electrostatic Imaging (BEI) to the task of impedance-based cellular-scale cancer screening and conduct a phantom study with a hyperconductive target to explore efficacy. It was shown that current BEI hardware could detect the phantom target at ranges exceeding seven-times the excitation length. Future study is needed to prove the result holds with miniaturization.